Literature DB >> 24859322

Effects of the recreational use of PDE5 inhibitors on the corpus cavernosum of young, healthy rats.

Abdulmuttalip Simsek1, Volkan Tugcu, Pelin Erturkuner, Faruk Alkan, Emin Ozbek, Ali Ihsan Tasci.   

Abstract

PURPOSE: PDE5 inhibitors are widely used for the treatment of erectile dysfunction. However, these drugs have recently become popular among men without erectile dysfunction as a means of enhancing sexual performance and improving sexual desire. The aim of this study was to investigate the histopathological and ultrastructural effects of PDE5 inhibitors on the corpus cavernosum in young, healthy male rats.
METHODS: Twenty-four 4-month-old male rats were divided into four groups: group 1 was the control group, group 2 rats received sildenafil citrate, group 3 rats received vardenafil hydrochloride, and group 4 rats received tadalafil. All drugs were administered for 4 weeks. Penile tissue was collected for electron microscopy and tissue collagen measurements. Electron microscopic analysis indicated that the number of active fibroblasts and macrophages and the synthesis of new collagen fibers increased in treated rats.
RESULTS: Cavernous tissue collagen levels were significantly higher in the sildenafil-, vardenafil-, and tadalafil-treated groups than in controls (46.16 ± 4.9, 42.06 ± 2.4, 41.07 ± 2.4, and 29.20 ± 3.3, respectively) (p < 0.001).
CONCLUSIONS: Young men who use these drugs to enhance performance in the absence of erectile dysfunction may experience irreversible damage to the cavernosal tissue. However, more studies are needed to evaluate the molecular mechanisms by which PDE5 inhibitors affect the corpus cavernosum.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859322     DOI: 10.1007/s11255-014-0746-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

1.  Hemodynamic effects of sildenafil in men with severe coronary artery disease.

Authors:  H C Herrmann; G Chang; B D Klugherz; P D Mahoney
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

Review 2.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

Review 3.  Role of nitric oxide in the physiology of erection.

Authors:  A L Burnett
Journal:  Biol Reprod       Date:  1995-03       Impact factor: 4.285

4.  Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitro.

Authors:  David R J Glenn; Carmel M McVicar; Neil McClure; Sheena E M Lewis
Journal:  Fertil Steril       Date:  2007-02-28       Impact factor: 7.329

5.  Sildenafil (Viagra) is used as a recreational drug in England.

Authors:  J Aldridge; F Measham
Journal:  BMJ       Date:  1999-03-06

6.  Epistaxis after PDE-5 inhibitors misuse.

Authors:  G Pomara; G Morelli; F Menchini-Fabris; N Dinelli; G Campo; G LiGuori; C Selli
Journal:  Int J Impot Res       Date:  2006 Mar-Apr       Impact factor: 2.896

7.  Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Authors:  M Boolell; M J Allen; S A Ballard; S Gepi-Attee; G J Muirhead; A M Naylor; I H Osterloh; C Gingell
Journal:  Int J Impot Res       Date:  1996-06       Impact factor: 2.896

8.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

9.  Does marijuana use play a role in the recreational use of sildenafil?

Authors:  Marie L Eloi-Stiven; Naganna Channaveeraiah; Paul J Christos; Madelon Finkel; Rekha Reddy
Journal:  J Fam Pract       Date:  2007-11       Impact factor: 0.493

10.  Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men.

Authors:  Giorgio Pomara; Girolamo Morelli; Domenico Canale; Paolo Turchi; Carolina Caglieresi; Cecilia Moschini; Giovanni Liguori; Cesare Selli; Enrico Macchia; Enio Martino; Francesco Francesca
Journal:  Fertil Steril       Date:  2007-06-04       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.